| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/21/2000 | WO2000077225A1 A novel insulin signaling molecule |
| 12/21/2000 | WO2000077221A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production |
| 12/21/2000 | WO2000077211A1 Pyrexia-associated genes and pyrexia-associated proteins of plant |
| 12/21/2000 | WO2000077207A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 12/21/2000 | WO2000077201A1 Livin; inhibitor-of-apoptosis protein-3 (iap-3) |
| 12/21/2000 | WO2000077200A1 Receptor interacting protein rip3 |
| 12/21/2000 | WO2000077199A1 Cloning and expression of a novel 5-ht4 receptor |
| 12/21/2000 | WO2000077198A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 12/21/2000 | WO2000077197A1 47 human secreted proteins |
| 12/21/2000 | WO2000077195A1 Nucleic acid encoding novel egf-like growth factors |
| 12/21/2000 | WO2000077192A1 Reg-binding protein |
| 12/21/2000 | WO2000077191A1 Tumor necrosis factor related receptor, tr6 |
| 12/21/2000 | WO2000077190A2 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt |
| 12/21/2000 | WO2000077184A1 Caspase-8 crystals, models and methods |
| 12/21/2000 | WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods |
| 12/21/2000 | WO2000077178A1 IMMUNOLOGICAL CONTROL OF β-AMYLOID LEVELS IN VIVO |
| 12/21/2000 | WO2000077173A1 42 human secreted proteins |
| 12/21/2000 | WO2000077168A2 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS |
| 12/21/2000 | WO2000077166A2 Gene expression modulated in gastrointestinal inflammation |
| 12/21/2000 | WO2000077047A1 Dog gonadotropin releasing hormone receptor |
| 12/21/2000 | WO2000077046A1 A male-specific protein homologue involved in histocompatability |
| 12/21/2000 | WO2000077045A1 Novel protein and dna thereof |
| 12/21/2000 | WO2000077044A1 Use of soluble protein molecules expressed by the pancreas and kidney glomerulus |
| 12/21/2000 | WO2000077043A2 Dna vaccines for pets and sport animals |
| 12/21/2000 | WO2000077042A2 Parathyroid hormone receptor ligands |
| 12/21/2000 | WO2000077040A2 Human intracellular signaling molecules |
| 12/21/2000 | WO2000077038A2 P202 is a tumor suppressor |
| 12/21/2000 | WO2000077037A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/21/2000 | WO2000077035A2 Novel potassium channels and genes encoding these potassium channels |
| 12/21/2000 | WO2000077034A2 Amino acids from fish and soy proteins improve insulin sensitivity |
| 12/21/2000 | WO2000077033A1 Retro-inverso peptides derived from interleukin-6 |
| 12/21/2000 | WO2000077031A2 Muc1 ligands |
| 12/21/2000 | WO2000077030A1 Statine-derived tetrapeptide inhibitors of beta-secretase |
| 12/21/2000 | WO2000077029A1 Retro-inverso peptides derived from leukemia inhibitory factor |
| 12/21/2000 | WO2000077028A1 Retro-inverso peptides derived from interleukin-3 |
| 12/21/2000 | WO2000077026A1 49 human secreted proteins |
| 12/21/2000 | WO2000077023A1 48 human secreted proteins |
| 12/21/2000 | WO2000077022A1 50 human secreted proteins |
| 12/21/2000 | WO2000077021A1 48 human secreted proteins |
| 12/21/2000 | WO2000076985A1 Cyclo-imino depsipeptides and their utilization in controlling endoparasites |
| 12/21/2000 | WO2000076554A1 Ligand-conjugated oligomeric compounds |
| 12/21/2000 | WO2000076553A1 Use of viral vectors and charged molecules for gene therapy |
| 12/21/2000 | WO2000076552A1 Methods and compositions for control of bone formation via modulation of leptin activity |
| 12/21/2000 | WO2000076544A1 Aminotetralin derivative for the therapy of cardiovascular diseases |
| 12/21/2000 | WO2000076539A2 A method to improve protective immunity induced by polynucleotide vaccines |
| 12/21/2000 | WO2000076536A1 Use of adenosine to minimize reperfusion injury |
| 12/21/2000 | WO2000076535A1 Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c) |
| 12/21/2000 | WO2000076533A1 Hemoactive compositions and methods for their manufacture and use |
| 12/21/2000 | WO2000076532A1 νO-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHETICS |
| 12/21/2000 | WO2000076531A1 47 human secreted proteins |
| 12/21/2000 | WO2000076530A1 49 human secreted proteins |
| 12/21/2000 | WO2000076528A2 Pharmaceutical preparation containing proteins |
| 12/21/2000 | WO2000076497A1 Cancer therapy |
| 12/21/2000 | WO2000076456A2 Modulators of fibrosis |
| 12/21/2000 | WO2000076455A2 Chicken growth hormone releasing hormone receptor |
| 12/21/2000 | WO2000076454A2 Therapeutic compositions for ophthalmic use and therapeutic compositions for brain central lesions |
| 12/21/2000 | WO2000076450A2 Recombinant adenoviruses for the sodium/iodide symporter (nis) |
| 12/21/2000 | WO2000076437A1 Soluble keratin peptide |
| 12/21/2000 | WO2000076309A2 Non-human transgenic animals deficient in gas6 function and their use |
| 12/21/2000 | WO2000066736B1 Growth factor homolog zvegf4 |
| 12/21/2000 | WO2000053761A3 Human cytokine as ligand of the zalpha receptor and uses thereof |
| 12/21/2000 | WO2000053752A3 Promotion or inhibition of angiogenesis and cardiovascularization |
| 12/21/2000 | WO2000052167A8 Angiopoietin-related protein and nucleic acids |
| 12/21/2000 | WO2000052056A3 Anti-plasmodium compositions and methods of use |
| 12/21/2000 | WO2000052049A3 A method for purifying human growth hormone |
| 12/21/2000 | WO2000051647A3 Animal model of allergies |
| 12/21/2000 | WO2000050443A3 Secreted proteins and uses thereof |
| 12/21/2000 | WO2000050442A3 Secreted proteins and uses thereof |
| 12/21/2000 | WO2000050062A3 Methods and compositions for altering mucus secretion |
| 12/21/2000 | WO2000048631A3 Adjuvant and cell maturation agent |
| 12/21/2000 | WO2000048622A3 Method for inhibiting inflammatory responses |
| 12/21/2000 | WO2000048621A3 Methods and compositions for regulating protein-protein interactions |
| 12/21/2000 | WO2000046240A3 Polypeptides involved in immune response |
| 12/21/2000 | WO2000045834A3 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease |
| 12/21/2000 | WO2000045167A3 Non-invasive method for detecting target rna |
| 12/21/2000 | WO2000044391A3 Plasminogen kringle 4 region fragments and methods of use |
| 12/21/2000 | WO2000044366A3 Therapeutic compositions containing glutathione analogs |
| 12/21/2000 | WO2000035950A3 Reagents and methods useful for detecting diseases of the breast |
| 12/21/2000 | WO2000020041A8 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 12/21/2000 | WO1998021230A8 Cyclic peptides that bind to urokinase-type plasminogen activator receptor |
| 12/21/2000 | DE19928021A1 New nucleic acid encoding testis-specific calpain-11, useful for identifying specific inhibitors for treatment of fertility disorders |
| 12/21/2000 | DE19927764A1 New surfactant protein C ester, useful in compositions for treating adult or infant respiratory distress, has improved stability and activity |
| 12/21/2000 | DE19927740A1 Preparing an agent for diagnosis or control of microbial infection, useful particularly against Helicobacter, based on identification of essential genes in defective mutants |
| 12/21/2000 | DE19926041A1 Removing or separating viruses from potentially virus-containing samples using gel permeation chromatography on hydrophilic supports |
| 12/21/2000 | DE19925739A1 Therapeutikum mit einem Botulinum-Neurotoxin Agent with a botulinum neurotoxin |
| 12/21/2000 | CA2392514A1 Reg-binding protein |
| 12/21/2000 | CA2391364A1 47 human secreted proteins |
| 12/21/2000 | CA2391361A1 47 human secreted proteins |
| 12/21/2000 | CA2390946A1 49 human secreted proteins |
| 12/21/2000 | CA2387696A1 48 human secreted proteins |
| 12/21/2000 | CA2383048A1 49 human secreted proteins |
| 12/21/2000 | CA2383041A1 49 human secreted proteins |
| 12/21/2000 | CA2382769A1 42 human secreted proteins |
| 12/21/2000 | CA2382748A1 50 human secreted proteins |
| 12/21/2000 | CA2382743A1 48 human secreted proteins |
| 12/21/2000 | CA2382735A1 49 human secreted proteins |
| 12/21/2000 | CA2382185A1 48 human secreted proteins |
| 12/21/2000 | CA2378745A1 Ligand-conjugated oligomeric compounds |
| 12/21/2000 | CA2376970A1 Thermogenesis-associated genes and thermogenesis-associated proteins of plant |
| 12/21/2000 | CA2376956A1 Charged compounds facilitate viral transduction of cells |